ENvue Medical, Inc. FEED
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 239.00K | 653.00K | 312.00K | 722.00K | 494.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 239.00K | 653.00K | 312.00K | 722.00K | 494.00K |
| Cost of Revenue | 505.00K | 708.00K | 682.00K | 533.00K | 529.00K |
| Gross Profit | -266.00K | -55.00K | -370.00K | 189.00K | -35.00K |
| SG&A Expenses | 4.70M | 3.19M | 3.25M | 2.22M | 2.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.71M | 4.36M | 3.97M | 2.97M | 4.47M |
| Operating Income | -5.47M | -3.71M | -3.66M | -2.25M | -3.98M |
| Income Before Tax | -4.90M | -3.79M | -13.27M | 545.00K | -3.91M |
| Income Tax Expenses | -2.00K | 33.00K | -419.00K | 35.00K | 62.00K |
| Earnings from Continuing Operations | -4.90M | -3.82M | -12.85M | 510.00K | -3.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.90M | -3.82M | -12.85M | 510.00K | -3.97M |
| EBIT | -5.47M | -3.71M | -3.66M | -2.25M | -3.98M |
| EBITDA | -5.26M | -3.49M | -3.40M | -1.99M | -3.61M |
| EPS Basic | -23.71 | -82.53 | -148.44 | -10.90 | -12.38 |
| Normalized Basic EPS | -5.97 | -8.64 | -14.57 | 4.84 | -60.50 |
| EPS Diluted | -23.71 | -82.53 | -148.44 | -10.90 | -12.38 |
| Normalized Diluted EPS | -5.97 | -8.64 | -14.57 | 4.84 | -60.50 |
| Average Basic Shares Outstanding | 513.10K | 274.10K | 91.80K | 71.50K | 40.40K |
| Average Diluted Shares Outstanding | 513.10K | 274.10K | 91.80K | 71.50K | 40.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |